HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atmaram S Pai Panandiker Selected Research

Radiotherapy

1/2016Cognitive outcomes among survivors of focal low-grade brainstem tumors diagnosed in childhood.
9/2015Whole-Body Pediatric Neuroblastoma Imaging: 123I-mIBG and Beyond.
7/2014Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine glioma.
1/2014Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas.
6/2013Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma.
5/2013Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma.
4/2013Methods for image guided and intensity modulated radiation therapy in high-risk abdominal neuroblastoma.
3/2013Management and outcome of focal low-grade brainstem tumors in pediatric patients: the St. Jude experience.
1/2013Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature.
12/2010Irradiation of pediatric high-grade spinal cord tumors.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atmaram S Pai Panandiker Research Topics

Disease

6Neoplasms (Cancer)
01/2014 - 03/2010
5Neuroblastoma
09/2015 - 03/2010
4Diffuse Intrinsic Pontine Glioma
07/2014 - 11/2010
2Disease Progression
01/2016 - 03/2013
2Glioma (Gliomas)
01/2014 - 06/2013
1Extranodal Extension
09/2015
1Septic Shock (Toxic Shock Syndrome)
01/2014
1Neuroepithelial Neoplasms (Gliomatosis Cerebri)
01/2014
1Pancreatitis
01/2014
1Central Nervous System Neoplasms
09/2013
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2013
1Rhabdoid Tumor (Rhabdoid Tumors)
04/2012
1Spinal Cord Neoplasms (Spinal Cord Tumors)
12/2010
1Neoplasm Metastasis (Metastasis)
12/2010
1Diarrhea
11/2010
1Posterior Leukoencephalopathy Syndrome
11/2010
1Hypertension (High Blood Pressure)
11/2010

Drug/Important Bio-Agent (IBA)

3dipinacoline glutamateIBA
07/2014 - 06/2013
23-Iodobenzylguanidine (Iobenguane)IBA
09/2015 - 03/2010
2ErbB Receptors (EGF Receptor)IBA
01/2014 - 11/2010
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2014 - 11/2010
2vandetanib (ZD6474)IBA
06/2013 - 11/2010
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2013 - 11/2010
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2014
1Drug CombinationsIBA
06/2013
1Dasatinib (BMS 354825)FDA Link
06/2013
1Platelet-Derived Growth FactorIBA
06/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2013
1Dihydrotachysterol (AT 10)IBA
03/2013
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2010

Therapy/Procedure

13Radiotherapy
01/2016 - 03/2010
2Therapeutics
04/2012 - 12/2010
1Drug Tapering
04/2013
1Adjuvant Chemotherapy
01/2013
1Craniospinal Irradiation
04/2012